Browsing by Author "Isaac, Echoru"

Now showing 1 - 5 of 5
  • Thumbnail Image
    ItemOpen Access
    Behavioural Response To Self-Medication Practice Before and During Covid-19 Pandemic in Western Uganda
    (Patient Preference and Adherence, 2022) Samuel Sunday, Dare; Ejike, Daniel Eze; Isaac, Echoru; Ibe Michael, Usman; Fred, Ssempijja; Edmund Eriya, Bukenya; Robinson, Ssebuufu
    Background: Self-medication has become a serious public health problem posing great risks, especially with the increasing number of cases of COVID-19 disease globally and in Uganda. This may be partly because of the absence of a recognized treatment for the disease, however, the differing prevalence and nature from country to country may influence human behavioral responses. Purpose: This study aimed to investigate the behavioral response to self-medication practices during the COVID-19 pandemic and lockdown in comparison to the pre-COVID period in Western Uganda. Methods: A descriptive cross-sectional survey was conducted from June to August 2020 in western Uganda using online Google forms and printed questionnaires to investigate the level of self-medication practice before and during the COVID-19 pandemic. This included 280 participants, aged 18 and above who consented to participate in the study. Participants were selected using a convenience sampling technique, and sampling was done by sending a structured online questionnaire via Google forms and printed questionnaires to participants who did not use the online Google forms. Results: Respondents that knew about self-medication were 97% of the 272 participants. Those that are aware of self-medication, have heard about it either through different avenues. Respondents who practiced self-medication before the COVID-19 pandemic were 239 (88%); those who practiced self-medication during the COVID-19 pandemic were 156 (57%); those that did not were 115 (43%). There was a statistically significant decrease in the number of respondents who practice self-medication during the COVID-19 pandemic lockdown compared to the practice before the pandemic lockdown. p < 0.05 at 95% confidence interval (OR = 5.39, 95% CI = 3.48, 8.32). Conclusion: Our investigation showed adequate knowledge of self-medication and a high level of self-medication practice with a decrease in self-medication practices during the COVID-19 pandemic lockdown compared to the practice before the lockdown
  • Thumbnail Image
    ItemOpen Access
    Low concentrations of Lactobacillus rhamnosus GG ( Yoba®) are safe in male Drosophila melanogaster
    (Research Note, 2019) Keneth Iceland, Kasozi; Aisha, Bukenya; Ejike, Daniel Eze; Josephine, Kasolo; Dickson Stuart, Tayebwa; Fred, Ssempijja; Joy, Suubo; Andrew, Tamale; Isaac, Echoru; Ibrahim, Ntulume; Sarah Kemuma, Onkoba; Lisa Nkatha, Micheni; Emmanuel Tiyo, Ayikobua; Oscar Hilary, Asiimwe; Muhamudu, Kalange
    Objective: The purpose of the study was to generate information on the safety of probiotics, thus the study objectives were to evaluate the effects of Yoba ® on basic physiochemical properties. The study assessed male w1118 Drosophila melanogaster which were provided food supplemented with Yoba ® at 1%, 3%, 6%, and 12% on motor function, total protein, catalase activity, and hydrogen peroxide scavenging activity and lifespan. Results: Yoba® at high concentration (≥ 6%) increased locomotor activity in Drosophila melanogaster, however, total protein, catalase, and hydrogen peroxide scavenging activity were significantly higher at 1% Yoba ® compared to 3%, 6%, and 12% Yoba ®. Yoba consumed at 1% was associated with greater physiological benefits in Drosophila melanogaster. Findings in the study offer a rationale for the consumption of Yoba ® at 1% in humans as is currently being promoted by the Yoba for Life consortium, however, high concentrations of Yoba ® would disrupt physiological function as shown by this study.
  • Thumbnail Image
    ItemOpen Access
    Low concentrations of Lactobacillus rhamnosus GG ( Yoba®) are safe in male Drosophila melanogaster
    (BMC Res Notes, 2019) Keneth Iceland, Kasozi; Aisha, Bukenya; Ejike, Daniel Eze; Josephine, Kasolo; Dickson Stuart, Tayebwa; Fred, Ssempijja; Joy, Suubo; Andrew, Tamale; Isaac, Echoru; Ibrahim, Ntulume; Sarah, Kemuma Onkoba; Lisa Nkatha, Micheni; Emmanuel Tiyo, Ayikobua; Oscar Hilary, Asiimwe; Muhamudu, Kalange
    Objective: The purpose of the study was to generate information on the safety of probiotics, thus the study objectives were to evaluate the effects of Yoba ® on basic physiochemical properties. The study assessed male w1118 Drosophila melanogaster which were provided food supplemented with Yoba ® at 1%, 3%, 6%, and 12% on motor function, total protein, catalase activity, and hydrogen peroxide scavenging activity and lifespan. Results: Yoba® at high concentration (≥ 6%) increased locomotor activity in Drosophila melanogaster, however, total protein, catalase, and hydrogen peroxide scavenging activity were significantly higher at 1% Yoba ® compared to 3%, 6%, and 12% Yoba ®. Yoba consumed at 1% was associated with greater physiological benefits in Drosophila melanogaster. Findings in the study offer a rationale for the consumption of Yoba ® at 1% in humans as is currently being promoted by the Yoba for Life consortium, however, high concentrations of Yoba ® would disrupt physiological function as shown by this study.
  • Thumbnail Image
    ItemOpen Access
    Pandemic panic and anxiety in developing countries. Embracing One Health offers practical strategies in management of COVID-19 for Africa
    (The Pan African Medical Journal., 2020) Keneth Iceland, Kasozi; Regan, Mujinya; Paul, Bogere; Isaac, Echoru; Simon Peter, Musinguzi
    The coronavirus, COVID-19 outbreak has now affected over 60% of African countries in less than two months [1], gaining a foothold through major economic and transport hubs on the African continent including Egypt, Algeria, Nigeria, South Africa and Kenya. Travel restrictions imposed against citizens from countries with major outbreaks including China, USA and those in Europe were too late [2,3]. African Union member states as of early April 2020 are reporting 6,470 cases and 241 deaths from COVID-19 reporting growth as “close to exponential”.
  • Thumbnail Image
    ItemOpen Access
    Sociodemographic factors associated with acceptance of COVID-19 vaccine and clinical trials in Uganda: a cross-sectional study in western Uganda
    (BMC Public Health, 2021) Isaac, Echoru; Patricia, Decanar Ajambo; Emmanuel, Keirania; Edmund E. M, Bukenya
    Background: Health experts agree that widespread use of safe and effective vaccines will rapidly contain the COVID-19 pandemic. The big question is whether these vaccines can easily be accepted by their end-users. Our study aimed at determining sociodemographic factors associated with acceptance of vaccines and clinical trials of COVID-19 in western Uganda. Method: A simplified snowball sampling technique was used to select 1067 respondents of 18–70 years in western Uganda using an online questionnaire from July to September 2020. Vaccine acceptability and risk perception were assessed using odds ratio at 95% confidence interval in R software version 3.6.3. Results: There were 1067 participants in the study. The majority were males (73.2%) and age group 31– 40 years (32.6%). The acceptance rate for COVID-19 vaccination was (53.6%; 572/1067) with those aged 18–20 years, males, elites at tertiary level of education (degree or diploma), students, Muslims, married, non-salary earners and rural dwellers having better odds and likeliness to accept vaccination. Only 44.6% (476/1067) showed interest in clinical trials among which; males, primary school leavers, students, Christians, un-married, respondents who didn’t earn any salary and rural dwellers had better odds and likelihood to participate in clinical trials. Conclusion: There was a low level of vaccine acceptance and clinical trial interest in western Uganda. Minority groups in the study i.e., Muslims, students, primary school leavers, un-married rural dwellers among others showed more interest in vaccination and clinical trials. We anticipated fears in the larger part of this community that health experts need to address through reassurance of the community that vaccines are tested and that they are safe and important if we are to rapidly contain the COVID-19 pandemic.